The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
Iron deficiency anemia (IDA) is the most common form of nutritional anemia worldwide. Iron plays a pivotal role in vital functioning of almost every organ system. IDA affects both physical and psychological functioning of humans. Oral iron is considered as first-line therapy for the treatment of IDA...
Main Authors: | Pramoda Koduru, Bincy P. Abraham |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X15616577 |
Similar Items
-
Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
by: Melvin H. Seid, et al.
Published: (2017-01-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
by: Sakiyeva Kanshaiym, et al.
Published: (2020-01-01) -
Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
by: Ahmed Hagras, et al.
Published: (2022-12-01) -
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
by: Iftikhar Hussain, et al.
Published: (2013-01-01)